Seattle Genetics (SGEN) PT Raised to $105 at Leerink Partners
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
- Oil prices gain on attacks in Saudi Arabia, Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
Tweet
Share
E-mail
Get Alerts SGEN Hot Sheet
Price: $228.74 --0%
Rating Summary:
10 Buy, 18 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 12 | New: 90
Rating Summary:
10 Buy, 18 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 12 | New: 90
Join SI Premium – FREE
Leerink Partners analyst Andrew Berens raised the price target on Seattle Genetics (NASDAQ: SGEN) to $105.00 (from $101.00) while maintaining a Outperform rating.
Berens is raising Adcetris estimates on unanticsurvival surviable benefit.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JD.com, Inc (JD) PT Lowered to $33 at US Tiger Securities
- Alliant Energy (LNT) PT Lowered to $75 at BMO Capital
- Norwegian Cruise (NCLH) PT Lowered to $22 at Stifel
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
Andrew BerensSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
